Search

Your search keyword '"cystic fibrosis transmembrane conductance regulator (CFTR)"' showing total 388 results

Search Constraints

Start Over You searched for: Descriptor "cystic fibrosis transmembrane conductance regulator (CFTR)" Remove constraint Descriptor: "cystic fibrosis transmembrane conductance regulator (CFTR)"
388 results on '"cystic fibrosis transmembrane conductance regulator (CFTR)"'

Search Results

1. CFTR Inhibitors Display Antiviral Activity against Herpes Simplex Virus.

Catalog

Books, media, physical & digital resources

3. Cystic Fibrosis

5. CFTR Inhibitors Display Antiviral Activity against Herpes Simplex Virus

7. Advances in the Cystic Fibrosis Drug Development Pipeline.

8. Elexacaftor Mediates the Rescue of F508del CFTR Functional Expression Interacting with MSD2.

10. Differential effects of ELX/TEZ/IVA on organ-specific CFTR function in two patients with the rare CFTR splice mutations c.273+1G>A and c.165-2A>G.

11. Differential effects of ELX/TEZ/IVA on organ-specific CFTR function in two patients with the rare CFTR splice mutations c.273+1G>A and c.165-2A>G

13. Advances in the Cystic Fibrosis Drug Development Pipeline

14. Biphasic regulation of CFTR expression by ENaC in epithelial cells: The involvement of Ca2+-modulated cAMP production

16. One Size Does Not Fit All: The Past, Present and Future of Cystic Fibrosis Causal Therapies.

17. Pharmacological Effects of Panduratin A on Renal Cyst Development in In Vitro and In Vivo Models of Polycystic Kidney Disease.

18. A small molecule CFTR potentiator restores ATP‐dependent channel gating to the cystic fibrosis mutant G551D‐CFTR.

19. Genotype-phenotype correlations of cystic fibrosis in siblings compound heterozygotes for rare variant combinations: Review of literature and case report

20. CFTR-mediated anion secretion in parathyroid hormone-treated Caco-2 cells is associated with PKA and PI3K phosphorylation but not intracellular pH changes or Na+/K+-ATPase abundance

23. One Size Does Not Fit All: The Past, Present and Future of Cystic Fibrosis Causal Therapies

24. 双肺移植治疗儿童囊性纤维化的多学科综合诊疗.

25. Global research trends on the absence of vas deferens: a bibliometric and visualized study

27. Was ist gesichert in der Therapie der Mukoviszidose?

28. Parathyroid hormone increases CFTR expression and function in Caco-2 intestinal epithelial cells.

29. Genetic diagnosis in practice: From cystic fibrosis to CFTR-related disorders.

30. The CYSMA web server: An example of integrative tool for in silico analysis of missense variants identified in Mendelian disorders.

31. Cystic Fibrosis

32. NBD2 Is Required for the Rescue of Mutant F508del CFTR by a Thiazole-Based Molecule: A Class II Corrector for the Multi-Drug Therapy of Cystic Fibrosis

33. Identification of GLPG/ABBV-2737, a Novel Class of Corrector, Which Exerts Functional Synergy With Other CFTR Modulators

34. Human epididymis protein 4 (HE4) protects against cystic pulmonary fibrosis associated-inflammation through inhibition of NF-κB and MAPK singnaling.

35. Identification of GLPG/ABBV-2737, a Novel Class of Corrector, Which Exerts Functional Synergy With Other CFTR Modulators.

36. Quantitative Evaluation of CFTR Pre-mRNA Splicing Dependent on the (TG)mTn Poly-Variant Tract

37. Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Ubiquitylation as a Novel Pharmaceutical Target for Cystic Fibrosis

38. A Novel Genetically Encoded Single Use Sensory Cellular Test System Measures Bicarbonate Concentration Changes in Living Cells

41. IMPACT OF SMOKING ON THE MAIN PATHOGENETIC LINKS OF COMORBID COURSE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND CHRONIC PANCREATITIS.

42. Gastrointestinal pathophysiology and nutrition in cystic fibrosis.

43. Multi-disciplinary team of the treatment of bilateral lung transplantation for pediatric cystic fibrosis

44. One Size Does Not Fit All: The Past, Present and Future of Cystic Fibrosis Causal Therapies

45. Cerebral artery myogenic reactivity: The next frontier in developing effective interventions for subarachnoid hemorrhage.

46. Biopolymer-Based Nanoparticles for Cystic Fibrosis Lung Gene Therapy Studies.

47. Tubular lipid binding proteins (TULIPs) growing everywhere.

48. Large-conductance Ca2+-activated K+ channel activation by apical P2Y receptor agonists requires hydrocortisone in differentiated airway epithelium.

49. High-expressing cystic fibrosis transmembrane conductance regulator interacts with histone deacetylase 2 to promote the development of Ph+ leukemia through the HDAC2-mediated PTEN pathway.

50. Elexacaftor/VX-445-mediated CFTR interactome remodeling reveals differential correction driven by mutation-specific translational dynamics.